These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31390578)

  • 1. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma.
    Xie C; Yiu W; Mo Y
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):116-124. PubMed ID: 38650144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
    Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
    Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
    Luo L; Zhou H; Su H
    BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes and signalling pathways in clear cell renal cell carcinoma: An integrated bioinformatics approach.
    S V; Balasubramanian S; Perumal E; Santhakumar K
    Cancer Biomark; 2024; 40(1):111-123. PubMed ID: 38427469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma.
    Pan KH; Yao L; Chen Z; Sun J; Jia Z; Zhang J; Ling Z
    Eur J Med Res; 2023 Sep; 28(1):356. PubMed ID: 37726833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential biomarkers for progression and prognosis of renal clear cell carcinoma by comprehensive bioinformatics analysis.
    Dong H; He Z; Wang H; Ding M; Huang Y; Li H; Shi H; Mao L; Hu C; Wang J
    Technol Health Care; 2024; 32(2):897-914. PubMed ID: 37483037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Differentially Methylated Genes Associated with Clear Cell Renal Cell Carcinoma and Their Prognostic Values.
    Wan B; Yang Y; Zhang Z
    J Environ Public Health; 2023; 2023():8405945. PubMed ID: 36793506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression analysis identifies a prognostically significant extracellular matrix-enriched gene signature in hyaluronan-positive clear cell renal cell carcinoma.
    Jokelainen O; Rintala TJ; Fortino V; Pasonen-Seppänen S; Sironen R; Nykopp TK
    Sci Rep; 2024 May; 14(1):10626. PubMed ID: 38724670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of bioinformatics analysis to identify possible hub genes and important pathways associated with clear cell renal cell carcinoma.
    Kumar A; Yadav RP; Chatterjee S; Das M; Pal DK
    Urologia; 2024 May; 91(2):261-269. PubMed ID: 38159064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel biomarkers to distinguish clear cell and non-clear cell renal cell carcinoma using bioinformatics and machine learning.
    Panwoon C; Seubwai W; Thanee M; Sangkhamanon S
    PLoS One; 2024; 19(6):e0305252. PubMed ID: 38857246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRYL1 is a Potential Prognostic Biomarker of Clear Cell Renal Cell Carcinoma Correlated with Immune Infiltration and Cuproptosis.
    Li P; Xu Q; Liu K; Ye J
    Technol Cancer Res Treat; 2024; 23():15330338241237439. PubMed ID: 38497139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC).
    Du GW; Yan X; Chen Z; Zhang RJ; Tuoheti K; Bai XJ; Wu HH; Liu TZ
    Aging (Albany NY); 2020 May; 12(9):8484-8505. PubMed ID: 32406866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic Analysis and Clinical Case Studies Identify CD276 as a Promising Diagnostic Biomarker for Clear Cell Renal Cell Carcinoma.
    Zhang Z; Xu J; Song Z; Zhang J; Lin Y; Ouyang J
    Cancer Control; 2024; 31():10732748241250181. PubMed ID: 38669187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma.
    Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A
    Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology.
    Meng Z; Yuan B; Yang S; Fu X; Zhang B; Xu K; Bao P; Huang Y
    Medicine (Baltimore); 2023 Sep; 102(35):e34929. PubMed ID: 37657024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.
    Xue S; Jiang SQ; Li QW; Wang S; Li J; Yang S; Zhang HM; Xu YF; Wang LS; Zheng JH
    BMC Urol; 2018 Sep; 18(1):79. PubMed ID: 30200918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study.
    Chang Q; Sun J; Zhao S; Li L; Zhang N; Yan L; Fan Y; Liu J
    Aging (Albany NY); 2023 Nov; 15(23):13753-13775. PubMed ID: 38048211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low ACADM expression predicts poor prognosis and suppressive tumor microenvironment in clear cell renal cell carcinoma.
    Zhou L; Yin M; Guo F; Yu Z; Weng G; Long H
    Sci Rep; 2024 Apr; 14(1):9533. PubMed ID: 38664460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysis.
    Shen P; He X; Lan L; Hong Y; Lin M
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.